Tesamorelin

Tesamorelin Injectable

Tesamorelin Injectable

Category: Hormone Support & Athleticism

Tesamorelin is a Growth Hormone-Releasing Hormone (GHRH) analog that stimulates the pituitary gland to produce and release growth hormone (GH). While commonly used to reduce abdominal and visceral fat in HIV patients, improving their lipid profiles and body composition, its applications are expanding. It is increasingly recognized for its benefits in addressing metabolism, body fat, and growth hormone deficiencies.

One-Time Purchase $800

3-Pack Bundle $2,200

*GET DISCOUNTS WITH  MEMBERSHIPS

OPTIMIZE TODAY, OWN TOMORROW.

OPTIMIZE TODAY, OWN TOMORROW.

OPTIMIZE TODAY, OWN TOMORROW.

OPTIMIZE TODAY, OWN TOMORROW.

OPTIMIZE TODAY, OWN TOMORROW.

OPTIMIZE TODAY, OWN TOMORROW.

Frequently Asked Questions

  • BENEFITS

    • Improved Lipid Profiles: Tesamorelin positively impacts lipid metabolism by reducing triglyceride and LDL cholesterol levels, thereby lowering the risk of cardiovascular disease.
    • Enhanced Cognitive Function: Studies indicate that Tesamorelin can boost memory, focus, and overall cognitive performance, attributed to increased IGF-1 levels from stimulated growth hormone release.
    • Increased Muscle Mass and Physical Performance: By stimulating protein synthesis, Tesamorelin enhances muscle mass and strength, benefiting patients with muscle wasting and athletes seeking improved body composition and recovery.
    • Skin and Cardiovascular Health Benefits: Tesamorelin is linked to better skin health, including more collagen production and fewer wrinkles. It may also decrease carotid intima-media thickness, an atherosclerosis marker, suggesting potential cardiovascular advantages.
    • Metabolic Boost: Tesamorelin raises energy expenditure, improving overall metabolism and promoting fat reduction, especially in stubborn areas. This supports weight loss goals and improves body composition.
    BOOK NOW
  • CONTRAINDICATIONS

    • Pregnancy and Breastfeeding: Tesamorelin is not recommended for pregnant or breastfeeding women. The safety of Tesamorelin in these populations has not been established.
    • Active Cancer: Patients with active cancer should not use Tesamorelin unless a healthcare provider specifically recommends it, as Tesamorelin stimulates growth hormone.
    • Pituitary Gland Disorders: Patients with active cancer or a history of pituitary gland disorders should avoid Tesamorelin unless explicitly advised by a healthcare professional, due to its growth hormone-stimulating effects.

    BOOK NOW
  • POTENTIAL SIDE EFFECTS

    • Injection Site Reactions: Expect redness, swelling, or mild discomfort at the injection site. These typically resolve on their own.
    • Mild Flu-Like Symptoms: Some individuals, especially when first starting treatment, may experience fatigue, headache, or nausea.
    • Muscle and Joint Pain: Mild muscle or joint pain can occur, and in some instances, may become more pronounced.

    When to Contact Us (Seek Medical Advice if You Experience):

    • Fever of 100.4°F (38°C) or higher
    • Blistering at the injection site
    • Muscle aches, nausea, dizziness, or headache
    • Skin rash, severe itching, vomiting, or hives
    BOOK NOW
  • TIPS TO REDUCE SIDE EFFECTS

    Dosage and Administration

    • Start with a lower dose and gradually increase to minimize side effects.
    • Rotate injection sites to prevent irritation and reduce the risk of reactions.
    • Administer before bedtime to align with the body's natural growth hormone release and reduce unwanted side effects.

         Monitoring and Safety

    • Monitor blood sugar regularly, especially if you have pre-existing glucose intolerance or a history of diabetes. This includes fasting glucose levels and HbA1c.
    • Consult a healthcare provider regularly for proper dosage adjustments and monitoring of any adverse reactions, ensuring safe and effective use.

    BOOK NOW
  • HOW IT WORKS

    • Tesamorelin works by binding to GHRH receptors in the pituitary gland, stimulating the release of the body's own growth hormone (GH). This increased GH production leads to higher levels of insulin-like growth factor 1 (IGF-1). 
    • IGF-1 is vital for promoting fat breakdown (lipolysis), protein synthesis, and muscle development. This mechanism makes Tesamorelin highly effective in reducing visceral fat and improving overall body composition. 
    • Additionally, it enhances metabolic functions by positively influencing lipid metabolism and insulin sensitivity.

    BOOK NOW
  • EXPECTED EFFECTS

    • 1-2 Weeks: Patients typically notice improvements in sleep quality and initial reductions in visceral fat.
    • 4-6 Weeks: Significant reductions in abdominal fat and improvements in lipid profiles are often observed. Muscle mass and strength may also begin to improve during this period.
    • 8-12 Weeks: Full benefits become evident, including substantial reductions in visceral fat, enhanced cognitive function, and improvements in body composition. A phase III clinical trial reported a reduction of up to 15% in visceral adipose tissue in patients with HIV-associated lipodystrophy.
    • Long-Term: Continuous use of Tesamorelin can lead to sustained improvements in physical performance, reduced cardiovascular risk factors, and an enhanced overall quality of life.